Tilray | TRLY - Операционные расходы





Операционные расходы Изменить Дата
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Cronos Group USD 46.66M 4.93M 2026-03
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Moderna USD 1.78B 242M 2026-03
Organigram Holdings CAD 83.66M 24.44M 2025-12
Organon & Co USD 903M 387M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.54B 323.9M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12